Response by Bai et al to Letter Regarding Article, “Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis” [Letters to the Editor]

from #ORL via xlomafota13 on Inoreader http://ift.tt/2oUOrvi
via IFTTT